BridgeBio Pharma Inc (BBIO)
27.70
-0.08
(-0.31%)
USD |
NASDAQ |
May 08, 16:00
27.70
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Cash from Investing (TTM): 64.49M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 64.49M |
| December 31, 2023 | 54.03M |
| September 30, 2023 | 72.06M |
| June 30, 2023 | 181.24M |
| March 31, 2023 | 326.82M |
| December 31, 2022 | 453.15M |
| September 30, 2022 | 456.98M |
| June 30, 2022 | 369.09M |
| March 31, 2022 | 219.85M |
| December 31, 2021 | -200.83M |
| September 30, 2021 | -139.61M |
| Date | Value |
|---|---|
| June 30, 2021 | -243.63M |
| March 31, 2021 | -373.07M |
| December 31, 2020 | -52.99M |
| September 30, 2020 | -152.91M |
| June 30, 2020 | -305.20M |
| March 31, 2020 | -176.80M |
| December 31, 2019 | -217.25M |
| September 30, 2019 | -203.95M |
| June 30, 2019 | -7.214M |
| March 31, 2019 | -8.286M |
| December 31, 2018 | -21.04M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-373.07M
Minimum
Mar 2021
456.98M
Maximum
Sep 2022
6.213M
Average
-30.10M
Median
Cash from Investing (TTM) Benchmarks
| Pfizer Inc | -32.28B |
| Alnylam Pharmaceuticals Inc | -327.75M |
| Tandem Diabetes Care Inc | -64.47M |
| Regenxbio Inc | 190.94M |
| IDEAYA Biosciences Inc | -158.46M |